Literature DB >> 1856018

Oncogene proteins as biomarkers in the molecular epidemiology of occupational carcinogenesis. The example of the ras oncogene-encoded p21 protein.

P W Brandt-Rauf1.   

Abstract

The use of oncogene proteins as biomarkers offers a new approach to the molecular epidemiologic evaluation of occupational carcinogenesis. The ras oncogene-encoded p21 protein represents a prototype for this type of study, since it is known to be activated by common occupational carcinogens, is frequently found in human tumors of occupational concern, and, at least in certain instances, appears to be expressed relatively early in the disease process, allowing the possibility of early detection and intervention. Herein, we review our experience with the use of immunologic detection of p21 in cohorts with cancer or at risk for the development of cancer due to their occupational exposures. The results suggest that p21 (particularly when used with other oncoproteins and biomarkers such as PAH-DNA adducts) will indeed be a useful addition to the growing armamentarium of molecular epidemiologic biomarkers in the study of occupational carcinogenic mechanisms and in the detection and prevention of occupational cancers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856018     DOI: 10.1007/bf00406190

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  36 in total

1.  Serum oncogene proteins in foundry workers.

Authors:  P W Brandt-Rauf; S Smith; F P Perera; H L Niman; W Yohannan; K Hemminki; R M Santella
Journal:  J Soc Occup Med       Date:  1990

Review 2.  Oncogene activation in chemical carcinogenesis.

Authors:  A Balmain; K Brown
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

3.  Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.

Authors:  P W Brandt-Rauf; M R Pincus; J M Chen
Journal:  J Protein Chem       Date:  1989-12

Review 4.  Oncogenes and oncogene proteins.

Authors:  P W Brandt-Rauf; M R Pincus
Journal:  Occup Med       Date:  1987 Jan-Mar

Review 5.  New markers for monitoring occupational cancer: the example of oncogene proteins.

Authors:  P W Brandt-Rauf
Journal:  J Occup Med       Date:  1988-05

Review 6.  Oncogene proteins as molecular epidemiologic markers of cancer risk in hazardous waste workers.

Authors:  P Brandt-Rauf
Journal:  Occup Med       Date:  1990 Jan-Mar

7.  Immunohistochemical study of the ras oncogene expression in human breast lesions.

Authors:  N J Agnantis; C Petraki; P Markoulatos; D A Spandidos
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

Review 8.  Current magnitude of occupational disease in the United States. Estimates from New York State.

Authors:  P J Landrigan; S Markowitz
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

9.  Correlation between serum oncogene protein expression and the development of neoplastic disease in a worker exposed to carcinogens.

Authors:  P W Brandt-Rauf; H L Niman; S J Smith
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000

10.  Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.

Authors:  D A Spandidos; I B Kerr
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

View more
  6 in total

1.  Applications of new technology in molecular epidemiology and their relevance to occupational medicine.

Authors:  D Koh; A Seow; C N Ong
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

2.  Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride.

Authors:  I De Vivo; M J Marion; S J Smith; W P Carney; P W Brandt-Rauf
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

Review 3.  Biomarkers of gene expression: growth factors and oncoproteins.

Authors:  P W Brandt-Rauf
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

4.  Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.

Authors:  Malgorzata Banys-Paluchowski; Tanja Fehm; Wolfgang Janni; Bahriye Aktas; Peter A Fasching; Sabine Kasimir-Bauer; Karin Milde-Langosch; Klaus Pantel; Brigitte Rack; Sabine Riethdorf; Erich-Franz Solomayer; Isabell Witzel; Volkmar Müller
Journal:  BMC Cancer       Date:  2018-05-08       Impact factor: 4.430

Review 5.  Risk assessment of nickel carcinogenicity and occupational lung cancer.

Authors:  H M Shen; Q F Zhang
Journal:  Environ Health Perspect       Date:  1994-01       Impact factor: 9.031

Review 6.  Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.

Authors:  G N Wogan
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.